Biotech · Private company
Iantrek, Inc.
Track this companyFree. Adds Iantrek, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials44 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AlloSpan Canal Platform Bio-Reinforced CanaloplastyOpen-Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- C-Rex InstrumentPrimary Open Angle Glaucoma (POAG)ClinicalTrials.gov · fetched Nov 12, 2026
- CycloPen Cyclodialysis SystemOpen Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- CycloPen Micro-Interventional Cyclodialysis SystemOpen-angle Glaucoma (OAG)ClinicalTrials.gov · fetched Nov 12, 2026
- CycloPen Micro-Interventional Cyclodialysis System Post CataractOpen-angle Glaucoma (OAG)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle GlaucomaENROLLING_BY_INVITATION · started Apr 1, 2026ClinicalTrials.gov NCT07520175 · fetched Nov 12, 2026
- 5-Year Postoperative Outcomes of Patients Who Completed the CREST StudyENROLLING_BY_INVITATION · started Sep 15, 2025ClinicalTrials.gov NCT07480343 · fetched Nov 12, 2026
- A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle GlaucomaACTIVE_NOT_RECRUITING · started Aug 14, 2024ClinicalTrials.gov NCT06615661 · fetched Nov 12, 2026
- Study of the CycloPen Micro-Interventional System and Long-Term Clinical OutcomesACTIVE_NOT_RECRUITING · started Aug 17, 2022ClinicalTrials.gov NCT05506423 · fetched Nov 12, 2026